AndrewMatthewFarlandMD
Oncology • Winston Salem, NCAssistant Professor, Internal Medicine, Bowman Gray School of Medicine of Wake Forest Univ
Dr. Farland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
S Hawthorne Rd
Winston Salem, NC 27157Phone+1 336-716-3182Fax+1 336-713-5424
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2006 - 2009
Virginia Commonwealth University School of MedicineClass of 2006
Certifications & Licensure
NC State Medical License 2006 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 20 citationsSuccessful treatment of intravenously abused oral Opana ER‐induced thrombotic microangiopathy without plasma exchangePeter J. Miller, Andrew M. Farland, Mary Ann Knovich, Katharine Batt, John Owen
American Journal of Hematology. 2014-07-01 - 2 citationsComparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII.Ritu M Ramamurthy, Martin Rodriguez, Hannah C Ainsworth, Jordan Shields, Diane Meares
Frontiers in Immunology. 2022-01-01 - 7 citationsImplementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell DiseaseJena L Welch-Coltrane, Anthony A Wachnik, Meredith C.B. Adams, Cherie R Avants, Howard Blumstein
Pain Medicine. 2021-08-06
Abstracts/Posters
- Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian PopulationsAndrew M. Farland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic PurpuraAndrew M. Farland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
